Cargando…

Pseudo-resistance to anticancer drugs

Detalles Bibliográficos
Autores principales:	Davoli, Enrico, Zucchetti, Massimo, Giavazzi, Raffaella, Garattini, Silvio, Frapolli, Roberta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666839/ https://www.ncbi.nlm.nih.gov/pubmed/36407785 http://dx.doi.org/10.1177/17588359221136776

Ejemplares similares

Heterogeneity of paclitaxel distribution in different tumor models assessed by MALDI mass spectrometry imaging
por: Giordano, Silvia, et al.
Publicado: (2016)

Determination of Paclitaxel Distribution in Solid Tumors by Nano-Particle Assisted Laser Desorption Ionization Mass Spectrometry Imaging
por: Morosi, Lavinia, et al.
Publicado: (2013)

Tumor Delivery of Chemotherapy Combined with Inhibitors of Angiogenesis and Vascular Targeting Agents
por: Cesca, Marta, et al.
Publicado: (2013)

Quantitative determination of niraparib and olaparib tumor distribution by mass spectrometry imaging
por: Morosi, Lavinia, et al.
Publicado: (2020)

A Nanostructured Matrices Assessment to Study Drug Distribution in Solid Tumor Tissues by Mass Spectrometry Imaging
por: Giordano, Silvia, et al.
Publicado: (2017)

Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxel
por: Martinelli, M, et al.
Publicado: (2007)

3D Mass Spectrometry Imaging Reveals a Very Heterogeneous Drug Distribution in Tumors
por: Giordano, S., et al.
Publicado: (2016)

Pharmacokinetic Characterization of the DDAH1 Inhibitors ZST316 and ZST152 in Mice Using a HPLC-MS/MS Method
por: Mangoni, Arduino A., et al.
Publicado: (2022)

PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models
por: Morosi, Lavinia, et al.
Publicado: (2021)

A methodological approach to correlate tumor heterogeneity with drug distribution profile in mass spectrometry imaging data
por: Prasad, Mridula, et al.
Publicado: (2020)

Pseudo-Specialism
Publicado: (1882)

New activities for the anti-tumor agent trabectedin: taking two birds with one stone
por: D'Incalci, Maurizio, et al.
Publicado: (2013)

Special Issue “Anticancer Drugs”
por: Meegan, Mary J., et al.
Publicado: (2019)

Advances in Anticancer Drug Discovery
por: Reynisson, Jóhannes
Publicado: (2021)

Anticancer Platinum Drugs Update
por: Ciarimboli, Giuliano
Publicado: (2021)

Pricing vaccines and drugs in Europe: worth differentiating?
por: Garattini, Livio, et al.
Publicado: (2020)

Special Issue “Anticancer Drugs 2021”
por: Meegan, Mary J., et al.
Publicado: (2022)

Retinoids and breast cancer: new clues to increase their activity and selectivity
por: Garattini, Enrico, et al.
Publicado: (2012)

Safety and Quality of Generic Drugs: A Never Ending Debate Fostered by Economic Interests?
por: Garattini, Livio, et al.
Publicado: (2015)

Metastasizing capacity of tumour cells from spontaneous metastases of transplanted murine tumours.
por: Giavazzi, R., et al.
Publicado: (1980)

The wisdom of crowds and the repurposing of artesunate as an anticancer drug
por: Augustin, Yolanda, et al.
Publicado: (2015)

Adverse Reactions to Anticancer Drugs in the Oral Cavity
por: Di Fede, Olga, et al.
Publicado: (2018)

Anticancer drug R&D landscape in China
por: Zhao, Shen, et al.
Publicado: (2020)

Response to flavone acetic acid (NSC 347512) of primary and metastatic human colorectal carcinoma xenografts.
por: Giavazzi, R., et al.
Publicado: (1988)

Resistance and Pseudo-resistance to permethrin: the importance of controlling scabies
por: Rinaldi, Fabio, et al.
Publicado: (2023)

Leukæmia and Pseudo-Leukæmia
Publicado: (1877)

Resistance or pseudo-resistance?
por: Zanardi, R., et al.
Publicado: (2022)

Development and Validation of a HPLC–MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing Mice
por: Ceruti, Tommaso, et al.
Publicado: (2022)

Targeting anticancer drug-induced senescence in glioblastoma therapy
por: Tomicic, Maja T., et al.
Publicado: (2018)

Chemotherapy-induced neutropenia elicits metastasis formation in mice by promoting proliferation of disseminated tumor cells
por: Russo, Massimo, et al.
Publicado: (2023)

Habit cough: A pseudo-asthma syndrome
por: Weinberger, Miles, et al.
Publicado: (2023)

‘The same old story’: thoughts on authorized doses of anticancer drugs
por: Meriggi, Fausto, et al.
Publicado: (2020)

Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics
por: Fuso Nerini, Ilaria, et al.
Publicado: (2016)

Mechanisms of Anticancer Therapy Resistance: The Role of Cancer Stem Cells
por: Kazi, Julhash U.
Publicado: (2020)

Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures
por: Apolone, G, et al.
Publicado: (2005)

Pharmaceutical Strategy for Europe: Reflections on Public Health-Driven Drug Development, Regulation, and Policies
por: Garattini, Silvio, et al.
Publicado: (2021)

“Pharmacogenetics of Cancer” - Cancer Drug Resistance special issue
por: Mini, Enrico, et al.
Publicado: (2020)

The Italian consensus conference on psychological therapies for anxiety and depressive disorders: findings and recommendations
por: Barbato, Angelo, et al.
Publicado: (2022)

Anticancer drug R&D of gastrointestinal cancer in China: Current landscape and challenges
por: Shen, Lin
Publicado: (2022)

Mechanisms of Anticancer Drug Resistance in Hepatoblastoma
por: Marin, Jose J. G., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2hlcq8fdahb3rfuo61p3bsl9l8